ZFT-29833-19802
5 vaccinations
7 coded responses
46 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 323 / FL
- Registered
- 2021-02-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-17
Registered in v-safe
-
2021-02-17
Dose 1 — Pfizer-BioNTech
- 2021-02-17
-
2021-02-18
Survey response — days 1–6 daily, dose 1MedDRA: Hot flush — Feeling: GoodFree text: During my initial check-in, I forgot to mention that I experienced a flush of warmth shortly after the injection. It dissipated quickly and I have not experienced it again.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-03-03
-
2021-03-10
Dose 2 — Pfizer-BioNTech
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
-
2021-03-14
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Single swollen lymph node above collarbone -same side as vaccine injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-15
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Lymph node still swollen - see previous reportMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-16
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Lymph node still swollen-see previous reportMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-17
Survey response — day 7, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Lymph node still swollen but appears to be shrinkingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-06-09
- 2021-09-08
-
2021-10-11
Dose 3 — Pfizer-BioNTech
-
2022-03-10
Survey response — 12 months, dose 2MedDRA: Basal cell carcinoma, Skin neoplasm excision — Feeling: GoodFree text: A few basal cell skin cancers (all removed without issues)MedDRA releases: 2024-11 · check-in free text available
-
2022-04-25
Dose 4 — Pfizer-BioNTech
- 2022-04-26
- 2022-04-27
- 2022-04-28
- 2022-04-29
- 2022-04-30
- 2022-05-01
- 2022-05-02
- 2022-05-09
- 2022-05-16
- 2022-05-23
- 2022-05-30
- 2022-06-06
- 2022-07-25
-
2022-09-15
Dose 5 — Pfizer-BioNTech
- 2022-09-28
- 2022-09-29
- 2022-10-06
- 2022-10-13
- 2022-10-20
-
2022-10-27
Survey response — day 42, dose 5MedDRA: Office visit, Ophthalmic migraine — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Experienced an ocular migraine on two consecutive days this past week. Had never experienced one before. · Healthcare visit (other): Appointment with ophthalmologist for evaluation and diagnosis.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-27
Report sent to call center — day 42, dose 5Get care from a doctor or other healthcare professional1 call case(s)
- 2022-10-28
-
2022-10-28
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-12-15
- 2023-03-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-17 | Pfizer-BioNTech | |
| 2 | 2021-03-10 | Pfizer-BioNTech | |
| 3 | 2021-10-11 | Pfizer-BioNTech | No |
| 4 | 2022-04-25 | Pfizer-BioNTech | No |
| 5 | 2022-09-15 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-27 | Successful 2022-10-28 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): During my initial check-in, I forgot to mention that I experienced a flush of warmth shortly after the injection. It dissipated quickly and I have not experienced it again.
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Single swollen lymph node above collarbone -same side as vaccine injection
Systemic reaction (other): Lymph node still swollen - see previous report
Systemic reaction (other): Lymph node still swollen-see previous report
Release 5 — day 7, dose 2
Systemic reaction (other): Lymph node still swollen but appears to be shrinking
Release 11 — 12 months, dose 2
Symptoms: A few basal cell skin cancers (all removed without issues)
Release 12 — day 42, dose 5
Symptoms: Experienced an ocular migraine on two consecutive days this past week. Had never experienced one before.
Healthcare visit (other): Appointment with ophthalmologist for evaluation and diagnosis.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Basal cell carcinoma | · | · | ✓ |
| SD | Ophthalmic migraine | · | · | ✓ |
| SD | Skin neoplasm excision | · | · | ✓ |
| SRO | Hot flush | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release